Department of Surgery, Erasmus MC, Erasmus University, Rotterdam, the Netherlands.
Department of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Br J Surg. 2020 Jun;107(7):917-926. doi: 10.1002/bjs.11586. Epub 2020 Mar 24.
Evidence for an association between hospital volume and outcomes for liver surgery is abundant. The current Dutch guideline requires a minimum volume of 20 annual procedures per centre. The aim of this study was to investigate the association between hospital volume and postoperative outcomes using data from the nationwide Dutch Hepato Biliary Audit.
This was a nationwide study in the Netherlands. All liver resections reported in the Dutch Hepato Biliary Audit between 2014 and 2017 were included. Annual centre volume was calculated and classified in categories of 20 procedures per year. Main outcomes were major morbidity (Clavien-Dindo grade IIIA or higher) and 30-day or in-hospital mortality.
A total of 5590 liver resections were done across 34 centres with a median annual centre volume of 35 (i.q.r. 20-69) procedures. Overall major morbidity and mortality rates were 11·2 and 2·0 per cent respectively. The mortality rate was 1·9 per cent after resection for colorectal liver metastases (CRLMs), 1·2 per cent for non-CRLMs, 0·4 per cent for benign tumours, 4·9 per cent for hepatocellular carcinoma and 10·3 per cent for biliary tumours. Higher-volume centres performed more major liver resections, and more resections for hepatocellular carcinoma and biliary cancer. There was no association between hospital volume and either major morbidity or mortality in multivariable analysis, after adjustment for known risk factors for adverse events.
Hospital volume and postoperative outcomes were not associated.
大量证据表明医院手术量与肝脏手术结果之间存在关联。目前荷兰指南要求每个中心每年至少进行 20 例手术。本研究旨在使用全国性荷兰肝胆审计数据来研究医院手术量与术后结果之间的关系。
这是荷兰的一项全国性研究。纳入了 2014 年至 2017 年荷兰肝胆审计报告的所有肝切除术。计算了每年的中心手术量,并分为每年 20 例手术的类别。主要结果是主要发病率(Clavien-Dindo 分级 IIIA 或更高)和 30 天或住院死亡率。
在 34 个中心共进行了 5590 例肝切除术,中位数每年中心手术量为 35(IQR 20-69)例。总体主要发病率和死亡率分别为 11.2%和 2.0%。结直肠癌肝转移(CRLMs)切除术后死亡率为 1.9%,非 CRLMs 为 1.2%,良性肿瘤为 0.4%,肝细胞癌为 4.9%,胆管癌为 10.3%。高容量中心进行了更多的主要肝切除术,更多的肝细胞癌和胆管癌切除术。多变量分析调整已知不良事件风险因素后,医院手术量与主要发病率或死亡率之间无关联。
医院手术量与术后结果之间无关联。